经NAs治疗后乙型肝炎完全病毒学应答:探讨HBV RNA阴性的临床意义
摘要
关键词
全文:
PDF参考
[1]LAI C, YUEN M. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points[J]. Ann Intern Med, 2007,147(1): 58-61.
[2]田丽艳,詹爱琴,安轶,等.HBV RNA在经治慢乙肝低病毒血症患者中的临床意义[J].现代医药卫生:1-5.
[3]GIERSCH K, ALLWEISS L, VOLZ T, et al. Serum HBV pgRNA as a clinical marker for cccDNA activity[J]. J Hepatol, 2017,66(2): 460-462.
[4]WANG J, SHEN T, HUANG X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound[J]. J Hepatol, 2016,65(4): 700-710.
[5]孙俊.核苷(酸)类似物初治慢性乙型肝炎患者发生部分病毒学应答的影响因素分析[D].南昌大学,2023.
[6]吴元凯,陈淑如,林国莉,等.核苷(酸)类似物治疗慢性HBV感染者至HBV DNA阴转后ALT异常的因素分析[J].中山大学学报(医学科学版),2014,35(04):525-532.
[7]SHEN J, DAI J, ZHANG Y, et al. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study[J]. J Viral Hepat, 2021,28(11): 1587-1596.
[8]WANG J, YU Y, LI G, et al. Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients[J]. J Hepatol, 2017.
[9]LUO H, TAN N, KANG Q, et al. Hepatitis B virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues[J]. J Viral Hepat, 2020,27(3): 323-328.
[10]孙梅,谈国蕾,徐露露,等.在HBV DNA低于检测下限的乙型肝炎患者中HBV RNA的检测意义[J].肝脏,2024,29(10):1243-1246.
Refbacks
- 当前没有refback。